Threes, why are you worried that the current Board will do a Pharma deal that assigns value with the PPHM technology that Ronin and their supporters on this message board have called worthless? Delivering value for tech that Ronin plans on putting on development hold is a good thing, right?
Of course, I don't agree with the worthless tech characterization or the theme that the tech development should be set aside to invest in Avid. Avid has two new 1000 liter bioreactors ready to serve orders and another Myford facility expansion on standby for action if customers emerge. Why isn't that enough Avid investment while subscribing new customers?
Market Data 
Markets 
AI
